Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 3, 1997, Pages 137-145

  Loubeau, Martine ^a   Ahmad, Ali ^a   Toma, Emil ^a   Menezes, José ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

ADCC; HIV 1; Interleukin 15; NK activity

Indexed keywords

GLYCOPROTEIN GP 120; INTERLEUKIN 15; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 15;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0030694228     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199711010-00001     Document Type: Article

References (40)

1. Cease KB. Towards a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu Rev Immunol 1994; 12:923-89.
2. Sirianni MC, Tagliaferri F, Aiuti F. Pathogenesis of natural killer cell deficiency in AIDS. Immunol Today 1990;11:81-2.
3. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV-infection. Annu Rev Immunol 1995;13:487-512.
4. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47:187-376.
5. Brenner BG, Gryllis C, Wainberg MA. Role of antibody dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases. J Leukoc Biol 1991;50:628-40.
6. Ahmad A, Menezes J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J 1996;10:258-66.
7. Tyler DS, Nastala CL, Stanley SD, et al. Gp120-specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody. J Imnmnol 1989;142:1177-82.
8. Sirianni C, Soddus S, Malroni W, Arancia G, Aiuti F. Mechanism of defective natural killer cell activity in patients with AIDS is associated with detective distribution of tubulin. J Immunol 1988; 140:2565-8.
9. Ahmad A, Morisset R, Thomas R, Menezes J. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41 specific ADCC-mediating antibody titers in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:428-37.
10. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 1993;262:1011-18.
11. Weigent DA, Stanton GJ, Johnson HJ. Interleukin-2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun 1983;41:992-7.
12. Bonavida B, Katz J, Gottlieb M. Mechanism of defective NK cell activity in patients with AIDS and AIDS-related complex. Defective trigger on NK cells for NKCF production by target cells and partial restoration by IL-2. J Immunol 1986;137:1157-63.
13. Rook AH, Hooks JJ, Quinnan GV, et al. Interleukin-2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma interferon independent mechanism. J Immunol 1985;134:1503-7.
14. Schwartz DH, Merigan TC. Interleukin-2 in the treatment of HIV disease. Biotherapy 1990;2:119-36.
15. Bamford RN, Grant AJ, Burton JD, et al. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine provisionally designated IL-T, that stimulates T-cell proliferation and induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994;91:4940-4.
16. Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a novel T cell growth factor that interacts with the beta chain of interleukin-2 receptor. Science 1994;264:965-8.
17. Munger W, Dejoy SQ, Jeyaseelan SR, et al. Studies evaluating the antitumor activity and toxicity of IL-15, a new T cell growth factor: comparison with IL-2. Cell Immunol 1995;165:289-93.
18. Ahmad A, Loubeau M, Sharif-Askari E, Morrisset R, Menezes J. Impairment of natural killer (NK) activity of, and IL-15 production, by peripheral blood mononuclear cells (PBMC) of AIDS patients: augmentation of both NK and antibody-dependent cellular cytotoxicities (ADCC) by recombinant IL-15 [abstract 58]. Abstracts of the 1996 Annual Meeting of the Institute of Human Virology. J Acquir Immune Defic Syndr Hum Retrovirol 1996:12.
19. Pross HF, Callewart D, Rubin P. Assays for the NK cell cytotoxicity - their values and pitfalls. In: Lotzova E, ed. Immunobiology of natural killer cells. Boca Raton: CRC Press, 1986:87-90.
20. Ahmad A, Yao XA, Tanner JE, Cohen E, Menezes J. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:789-98.
21. Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996; 97:1373-81.
22. Patel PC, Menezes J. Epstein-Barr virus (EBV)-lymphoid cell interactions. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells. Clin Exp Immunol 1982;48:589-601.
23. Daniel WN. Biostatistics: a foundation of analysis in health sciences. 5th ed. Toronto: John Wiley & Sons, 1991:209-15.
24. Hu PF, Hultin LE, Hausner MA, et al. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+ CD56+ cells and expansion of a population of CD16dim CD56 cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:331-40.
25. Vuillier F, Bianco NE, Montagnier L, Dighiero G. Selective depletion of low-density CD8+ CD16+ lymphocytes during HIV infection. AIDS Res Hum Retroviruses 1988;4:121-129.
26. Mansour I, Doinel C, Rouger P. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of CD16+ CD8+ CD3- subset. AIDS Res Hum Retroviruses 1990;6:1451-7.
27. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J. Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis. J Immunol 1990;145: 3194-201.
28. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. Il-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995;154:483-90.
29. Giri JG, Ahdieh M, Eisenman J, et al. Utilization of the beta and gamma chains of the IL-2 receptor by a novel cytokine, IL-15. EMBO J 1994;13:2822-30.
30. Carson WE, Giri JG, Lindemann MJ, et al. Interleukin-15 is a novel cytokine that activates human natural killer cells via components of IL-2 receptor. J Exp Med 1994;180:1395-1403.
31. Takeshita T, Asao H, Ohtani K, et al. Cloning of the gamma chain of the human IL-2 receptor. Science 1992;257:379-82.
32. Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B. Mechanism of a defective NK cell activity in patients with acquired immunodeficiciency syndrome (AIDS) and AIDS-related complex. Normal antibody-dependent cellular cytotoxicity (ADCC)-mediated by effector cells defective in natural killer (NK) cytotoxicity. J Immunol 1987;139:55-60.
33. Ojo-Amaize E, Nishanian PG, Hietjan DF, et al. Serum and effector cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression. J Clin Immunol 1989;9:454-61.
34. Szelc CM, Mitcheltree C, Roberts RL, Steihm ER. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in paediatric and adult human immunodeficiency virus infection. J Infect Dis 1992;166:486-93.
35. Tyler DS, Stanley SD, Nastala CA, et al. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV infection: humoral and cellular defects. J Immunol 1990;144:3375-84.
36. Brenner BG, Dascal A, Margolese RG, Wainberg MA. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J Leukocyte Biol 1989;46:75-83.
37. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, Pedersen BK. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med 1995;182:789-99.
38. Seder RA, Grabstein HK, Berzofsky JA, Mc Dyer JF. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12 and 1L-15. J Exp Med 1995; 182:1067-78.
39. Ljunggren K, Karlson A, Fenyo EM, Jondal M. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection. Clin Exp Immunol 1989; 75:14-189.
40. De la Barrera S, Olabuenaga D, Felippo M, Elizade de Biacco M. Effect of lymphokines on natural killer cytotoxicity in patients with high risk of developing the acquired immune deficiency syndrome. Immunol Lett 1986;13:307-311.